These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33134275)

  • 1. Rapid
    Santini BL; Zacharias M
    Front Chem; 2020; 8():573259. PubMed ID: 33134275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Rational Design of Cyclic Peptides Mimicking Protein-Protein Interfaces.
    Santini BL; Zacharias M
    Methods Mol Biol; 2022; 2405():231-244. PubMed ID: 35298817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cation-pi interactions in biomolecular association. Design of peptides favoring interactions between cationic and aromatic amino acid side chains.
    Pletneva EV; Laederach AT; Fulton DB; Kostic NM
    J Am Chem Soc; 2001 Jul; 123(26):6232-45. PubMed ID: 11427046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic peptides: backbone rigidification and capability of mimicking motifs at protein-protein interfaces.
    Huang H; Damjanovic J; Miao J; Lin YS
    Phys Chem Chem Phys; 2021 Jan; 23(1):607-616. PubMed ID: 33331371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tertiary motifs as building blocks for the design of protein-binding peptides.
    Swanson S; Sivaraman V; Grigoryan G; Keating AE
    Protein Sci; 2022 Jun; 31(6):e4322. PubMed ID: 35634780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of Cyclic Peptides Targeting Protein-Protein Interactions Using AlphaFold.
    Kosugi T; Ohue M
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Match_Motif: A rapid computational tool to assist in protein-protein interaction design.
    Zacharias M
    Protein Sci; 2022 Jan; 31(1):147-157. PubMed ID: 34648221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Opportunities and Challenges in Finding Cyclic Peptide Modulators of Protein-Protein Interactions.
    Duffy F; Maheshwari N; Buchete NV; Shields D
    Methods Mol Biol; 2019; 2001():73-95. PubMed ID: 31134568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based derivation of peptide inhibitors to target TGF-β1 receptor for the suppression of hypertrophic scarring fibroblast activation.
    Hu H; Yang S; Zheng J; Mao G
    Chem Biol Drug Des; 2017 Sep; 90(3):345-351. PubMed ID: 28122173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation.
    Qvit N; Kornfeld OS
    J Vis Exp; 2016 Jan; (107):e53589. PubMed ID: 26863382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Des3PI: a fragment-based approach to design cyclic peptides targeting protein-protein interactions.
    Delaunay M; Ha-Duong T
    J Comput Aided Mol Des; 2022 Aug; 36(8):605-621. PubMed ID: 35932404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening using combinatorial cyclic peptide libraries reveals protein interfaces readily targetable by cyclic peptides.
    Duffy FJ; O'Donovan D; Devocelle M; Moran N; O'Connell DJ; Shields DC
    J Chem Inf Model; 2015 Mar; 55(3):600-13. PubMed ID: 25668361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage Selection of Cyclic Peptides for Application in Research and Drug Development.
    Deyle K; Kong XD; Heinis C
    Acc Chem Res; 2017 Aug; 50(8):1866-1874. PubMed ID: 28719188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico study of amphiphilic nanotubes based on cyclic peptides in polar and non-polar solvent.
    Vijayakumar V; Vijayaraj R; Peters GH
    J Mol Model; 2016 Nov; 22(11):264. PubMed ID: 27734210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure and in silico binding of a cyclic peptide with hepatitis B surface antigen.
    Muhamad A; Ho KL; Rahman MB; Uhrín D; Tan WS
    Chem Biol Drug Des; 2013 Jun; 81(6):784-94. PubMed ID: 23405984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of conformation on the solution stability of linear vs. cyclic RGD peptides.
    Bogdanowich-Knipp SJ; Jois DS; Siahaan TJ
    J Pept Res; 1999 May; 53(5):523-9. PubMed ID: 10424347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of type-IA receptor-derived cyclic peptides to target human bone morphogenic protein 2.
    Fan X; Xia H; Liu X; Li B; Fang J
    J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of cyclic peptides to disrupt TGF-Β/SMAD7 signaling in heterotopic ossification.
    Zhong B; Zhang C; Guo S; Zhang C
    J Mol Graph Model; 2017 Mar; 72():25-31. PubMed ID: 28013146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.